Edition:
United Kingdom

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

3.06CAD
15 Feb 2019
Change (% chg)

$-0.04 (-1.29%)
Prev Close
$3.10
Open
$3.09
Day's High
$3.11
Day's Low
$3.04
Volume
76,563
Avg. Vol
42,644
52-wk High
$4.31
52-wk Low
$1.11

Chart for

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 3.51
Market Cap(Mil.): $206.99
Shares Outstanding(Mil.): 114.62
Dividend: --
Yield (%): --

Financials

  RVX.TO Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -0.65 -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

Earnings vs. Estimates